FSSNX | LSCRX | FSSNX / LSCRX | |
Total Expense Ratio | 0.03 | 1.15 | 2% |
Annual Report Gross Expense Ratio | 0.03 | 1.21 | 2% |
Fund Existence | 14 years | 29 years | - |
Gain YTD | 10.332 | 4.658 | 222% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 2500 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 27.7B | 339M | 8,171% |
Annual Yield % from dividends | 0.84 | 0.03 | 3,358% |
Returns for 1 year | 11.86 | -4.84 | -245% |
Returns for 3 years | 53.63 | 3.01 | 1,784% |
Returns for 5 years | 72.56 | 5.08 | 1,429% |
Returns for 10 years | 121.40 | -28.11 | -432% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FLEU | 31.88 | 0.52 | +1.65% |
Franklin FTSE Eurozone ETF | |||
CCNR | 30.54 | 0.35 | +1.14% |
ALPS/CoreCommodity Natural Resources ETF | |||
ARKG | 26.91 | 0.24 | +0.90% |
ARK Genomic Revolution ETF | |||
MSLC | 54.07 | 0.29 | +0.54% |
Morgan Stanley Pathway Large Cap Eq ETF | |||
XSLV | 46.35 | 0.20 | +0.43% |
Invesco S&P SmallCap Low Volatility ETF |